R. Hiebert

Surface and Air Contamination With Severe Acute Respiratory Syndrome Coronavirus 2 From Hospitalized Coronavirus Disease 2019 Patients in Toronto, Canada, March–May 2020

Jalees A. Nasir, E. Bryce, A. McArthur, 2021, The Journal of Infectious Diseases.

Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial

J. Glenn, Deepali Kumar, A. Humar, 2021, The Lancet Respiratory Medicine.

Peginterferon-lambda for the treatment of COVID-19 in outpatients

J. Glenn, D. Tyrrell, Deepali Kumar, 2020, medRxiv.

Quantitative Assessment of Viral Dispersion Associated with Respiratory Support Devices in a Simulated Critical Care Environment

R. Fowler, R. Pinto, S. Mubareka, 2021, American journal of respiratory and critical care medicine.

Surface and air contamination with SARS-CoV-2 from hospitalized COVID-19 patients in Toronto, Canada

Jalees A. Nasir, E. Bryce, M. Veillette, 2021, medRxiv.

Reply to Tandjaoui-Lambiotte et al.: Viral Dispersion in the ICU: The Wind Effect

R. Fowler, S. Mubareka, H. Mbareche, 2021, American Journal of Respiratory and Critical Care Medicine.

Aerosol generation during pulmonary function testing: Monitoring during different testing modalities

G. Evans, S. Mubareka, C. Ryan, 2021, Canadian Journal of Respiratory, Critical Care, and Sleep Medicine.

Surface and Air Contamination With Severe Acute Respiratory Syndrome Coronavirus 2 From Hospitalized Coronavirus Disease 2019 Patients in Toronto, Canada, March–May 2020

Jalees A. Nasir, E. Bryce, M. Veillette, 2021, The Journal of infectious diseases.